Experimentelle und erste klinische Erfahrungen mit der Thrombolysetherapie mit rt-PA bei thrombotischen Zerebralarterienverschlüssen

Literatur
1 Brott T, Haley E.C, Levy D.E, Barsan W.G, Reed R.L, Olinger C.P, Marler J.R. Very early therapy for cerebral infarction with tissue plasminogen activator (t-PA). Stroke 1988; 19: Abstrl33.
2 Chehrazi B, Siebert A.J, Hein L, Brock J. Evaluation of tissue plasminogen activator (t-PA) in embolic stroke. Stroke 1988; 19: Abstrl33.
3 Del Zoppo G.J, Copeland B.R, Harker L.A, Waltz T.A, Zyroff J, Hanson S.R, Battenberg E. Experimental acute thrombotic stroke in baboons. Stroke 1986; 17: 1254-65.
4 Del Zoppo G.J, Copeland B.R, Waltz T.A, Zyroff J, Harker L.A. Thrombolytic therapy in a baboon model of acute stroke. Fibrinolysis. 1986 b 1. Abstr215.
5 Del Zoppo G.J, Zeumer H, Harker L.A. Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986; 17: 595-607.
6 Del Zoppo G.J, Copeland B.R, Hacke W, Dietrich J.E, Harker L.A. Intracerebral hemorrhage following rt-PA infusion in a primate stroke model. Stroke 1988; 19: Abstrl34.
7 Del Zoppo G.J, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, Harker L.A, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke 1988; 19: 307-13.
8 Fletcher A.P, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks J.E, Hardin W.B, Landau W.M, Raichle M.E. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7: 135-42.
9 Hacke W, del Zoppo G.J, Harker A. Thrombosis and cerebrovascular disease. In: Poeck K, Ringelstein E.B, Hacke W. (eds) New Trends in Diagnosis and Management of Stroke. Berlin, Heidelberg, New York: Springer; 1987: 59-74.
10 Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo G.J. Intra-arterial fibrinolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216-22.
11 Henze T, Boeer A, Tebbe U, Romatowski J. Lysis of basilar artery occlusion with tissue plasminogen activator. Lancet 1987; 1391.
12 Kissel P, Chehrazi B, Seibert J.A, Wagner F.C. Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator. J Neurosurg 1987; 67: 399-405.
13 Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 1981; 46: 561-5.
14 Meyer J.S, Herndon R.M, Gotoh F, Tazaki Y, Nelson J.N, Johnson J.F. Therapeutic thrombolysis. In: Millikan C.H, Siekert R.G, Whisnant J.P. (eds) Cerebral Vascular Disease, 3rd Princeton Conference. New York: Grune and Stratton; 1961: 160-77.
15 Papadopoulos S.M, Chandler W.F, Salamat M.S, Topol E.J, Sackellares J.C. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg 1987; 67: 394-8.
16 Penar P.L, Greer C.A. The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia. Yale J Biol Med 1987; 60: 233-43.
17 Phillips D.A, Fisher M, Smith T.W, Davis M.A. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model. Ann Neurol 1988; 23: 391-4.
18 Slivka A, Pulsinelli W. Hemorrhagic complications of thrombolytic therapy in experimental stroke. Stroke 1987; 18: 1148-56.
19 Sloan M.A. Thrombolysis and stroke. Past and future. Arch Neurol 1987; 44: 748-68.
19a Schmutzler R, Koller F. Die Thrombolyse-Thera-pie. Ergeb Inn Med Kinderheilk 1965; 22: 157.
20 Sussman B, Fitch T, Plainfield N. Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958; 167: 1705-9.
21 t-PA-Acute Stroke Study Group. An open multi-center study of the safety and efficacy of various doses of rt-PA in patients with acute stroke: preliminary results. Stroke 1988; 19: Abstrl34.
22 Watson B.D, Dietrich W.D, Busto R, Ginsberg M.D, Hoyng C.F. Influence of tissue-type plasminogen activator on blood flow during evolution of thrombotic stroke. Neuroscience 1985; 11: Abstr433.
23 Zeumer H. Vascular recanalizing techniques in interventional neuroradiology. J Neurol 1985; 231: 287-94.
23a Zeumer H, Hacke W, Kolmann H.L, Poeck K. Lokale Fibrinolysetherapie bei Basilaris-Thrombo-se. Dtsch med Wschr 1982; 107: 728-31.
24 Zeumer H, Hacke W, Ringelstein E.B. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR 1983; 4: 401-4.
25 Zeumer H, Ringelstein E.B, Hassel M, Poeck K. Lokale Fibrinolysetherapie bei subtotaler Stenose der A. cerebri media. Dtsch med Wschr 1983; 108: 1103-5.
25a Zimmermann R, Heuck C.C, Harenberg J, v. Kummer R, Schmidt-Gayk U, Simon B, Wahl P, Morl H, Weber P.G. Fibrinolytische Therapie einer schweren Arteria-basilaris-Thrombose. Dtsch med Wschr 1981; 106: 464-7.
26 Zivin J.A, Fisher M, DeGirolami U, Hemenway C.C, Stashak J.A. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985; 230: 1289-92.
27 Zivin J.A, Lyden P.D, DeGirolami U, Kochhar A, Mazzarella V, Hemenway C.C, Johnston P. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol 1988; 45: 387-91.